Compounds > 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol
Page last updated: 2024-08-26

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Experimental Mammary Neoplasms

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, JM; Lappin, TR; MacManus, MP; McAleer, JJ; McKeown, SR1
Chaplin, DJ; Horsman, MR; Overgaard, J1

Other Studies

2 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Experimental Mammary Neoplasms

ArticleYear
Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
    International journal of radiation oncology, biology, physics, 1992, Volume: 23, Issue:3

    Topics: Animals; Biotransformation; Cell Hypoxia; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Mice, Inbred Strains; Misonidazole; Radiation-Sensitizing Agents; Tirapazamine; Triazines

1992
The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
    Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:6b

    Topics: Animals; Combined Modality Therapy; Female; Hydralazine; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Misonidazole

1988